TrialESMO open2020

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial.

Andrea Sartore-Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.